Fig. 6From: Upregulation of the EMT marker vimentin is associated with poor clinical outcome in acute myeloid leukemiaSurvival analysis of patients with AML associated with VIM expression in three different datasets. Overall survival of patients with AML in various datasets after dichotomization of VIM mRNA expression into high and low according to the log-2 median-centered expression: a, b CN-AML (Metzeler, Blood, 2008) and c CN-AML and CA-AML (Bullinger, NEJM, 2004)Back to article page